Skip to main content
. 2024 Feb 17;14(2):e083488. doi: 10.1136/bmjopen-2023-083488

Figure 1.

Figure 1

THRIVE study flow chart. DHRA, Department of Health Risk Assessment; DOAC, direct-acting oral anticoagulant; DVT, deep vein thrombosis; ICER, incremental cost-effectiveness ratio; LMWH, low-molecular-weight heparin; VTE, venous thromboembolism.